“…These diseases also serve as important model systems for neurodegeneration owing to the retina’s experimental tractability ( Tirassa et al, 2018 ; Trapani and Auricchio, 2018 ). Recent advances in optoelectronics have enabled high-resolution retinal prosthetics ( Ha et al, 2016 ; Yang et al, 2016 ; Bosse et al, 2018 ; Edwards et al, 2018 ; Palanker et al, 2020 ), new gene therapy strategies also show promise ( Trapani and Auricchio, 2018 ; Wood et al, 2019 ; Sahel et al, 2021 ; Cehajic-Kapetanovic et al, 2022 ), and advances in stem cell research has allowed for the transplantation of new photoreceptors ( Ludwig and Gamm, 2021 ; Ribeiro et al, 2021 ; Zerti et al, 2021 ); however, there is much concern about how disease related changes impact the fidelity of restored vision ( Dräger and Hubel, 1978 ; Sauvé et al, 2001 ; Stasheff, 2008 , 2018 ; Toychiev et al, 2013 ; Yee et al, 2014 ; Ivanova et al, 2016 ; Jones et al, 2016 ; Telias et al, 2019 , 2022 ; Zerti et al, 2021 ). Although, some interactions between disease related changes and prosthetic vision restoration have been studied in the past ( Ryu et al, 2011 ; Yee et al, 2012 ; Goo et al, 2015 ; Cho et al, 2016 ; Stutzki et al, 2016 ; Ahn et al, 2022 ), many important questions remain unresolved, such as how degeneration changes spatiotemporal processing in retinal circuitry.…”